Lin, N., Song, Y., Zhang, X., Xie, G., Ma, X., Zhu, J. (2025). Real-world characteristics, treatment patterns, and outcomes of patients with mantle cell lymphoma (MCL) after receiving covalent bruton tyrosine kinase inhibitors (cBTKi) in China. Blood. https://doi.org/10.1182/blood-2025-2704